Insider · CIK 0001704251

Tilton John

Reports to the SEC for 1 company · NEW HAVEN, CT

sec.gov

Transactions

Companies

Filings

CIK

0001704251

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.D Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	−5,068 sh	$148.50	−$753K	1,614
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.D Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	−1,614 sh	$148.50	−$240K	0
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Restricted Share Unit AwardD Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	−2,625 sh	—	—	0
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Restricted Share Unit AwardD Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	−2,500 sh	—	—	0
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Restricted Share Unit AwardD Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	−1,250 sh	—	—	0
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Stock Options (Right to Buy)D Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	−775 sh	—	—	0
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Stock Options (Right to Buy)D Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	−6,225 sh	—	—	0
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Stock Options (Right to Buy)D Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	−2,398 sh	—	—	0
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Stock Options (Right to Buy)D Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	−7,602 sh	—	—	0
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Stock Options (Right to Buy)D Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	−10K sh	—	—	0
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Stock Options (Right to Buy)D Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	−26.9K sh	—	—	0
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Stock Options (Right to Buy)D Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	−3,084 sh	—	—	0
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Stock Options (Right to Buy)D Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	−19.2K sh	—	—	0
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Stock Options (Right to Buy)D Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	−2,500 sh	—	—	0
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Stock Options (Right to Buy)D Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	−4,000 sh	—	—	0
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Stock Options (Right to Buy)D Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	−37.3K sh	—	—	0
2022-01-07	Biohaven Pharmaceutical Holding Co Ltd.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+875 sh	—	—	5,279
2022-01-07	Biohaven Pharmaceutical Holding Co Ltd.F Tax Payment	Chief Commercial Officer	FTax Payment	−342 sh	$128.87	−$44.1K	4,937
2022-01-07	Biohaven Pharmaceutical Holding Co Ltd.Employee Stock Option (right to buy)A Award	Chief Commercial Officer	AAward	+7,000 sh	—	—	7,000
2022-01-07	Biohaven Pharmaceutical Holding Co Ltd.Restricted Share Unit AwardA Award	Chief Commercial Officer	AAward	+3,500 sh	—	—	3,500
2022-01-07	Biohaven Pharmaceutical Holding Co Ltd.Restricted Share Unit AwardM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−875 sh	—	—	2,625
2022-01-06	Biohaven Pharmaceutical Holding Co Ltd.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+1,250 sh	—	—	4,955
2022-01-06	Biohaven Pharmaceutical Holding Co Ltd.F Tax Payment	Chief Commercial Officer	FTax Payment	−551 sh	$123.86	−$68.2K	4,404
2022-01-06	Biohaven Pharmaceutical Holding Co Ltd.Restricted Share Unit AwardM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−1,250 sh	—	—	2,500
2021-11-25	Biohaven Pharmaceutical Holding Co Ltd.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+1,250 sh	—	—	3,909
2021-11-25	Biohaven Pharmaceutical Holding Co Ltd.F Tax Payment	Chief Commercial Officer	FTax Payment	−492 sh	$115.55	−$56.9K	3,417
2021-11-25	Biohaven Pharmaceutical Holding Co Ltd.Restricted Share Unit AwardM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−1,250 sh	—	—	1,250
2021-01-06	Biohaven Pharmaceutical Holding Co Ltd.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+1,250 sh	—	—	3,151
2021-01-06	Biohaven Pharmaceutical Holding Co Ltd.F Tax Payment	Chief Commercial Officer	FTax Payment	−492 sh	$83.38	−$41K	2,659
2021-01-06	Biohaven Pharmaceutical Holding Co Ltd.Employee Stock Option (right to buy)A Award	Chief Commercial Officer	AAward	+10K sh	—	—	10,000
2021-01-06	Biohaven Pharmaceutical Holding Co Ltd.Restricted Share Unit AwardA Award	Chief Commercial Officer	AAward	+5,000 sh	—	—	5,000
2021-01-06	Biohaven Pharmaceutical Holding Co Ltd.Restricted Share Unit AwardM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−1,250 sh	—	—	3,750
2020-11-25	Biohaven Pharmaceutical Holding Co Ltd.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+1,250 sh	—	—	2,020
2020-11-25	Biohaven Pharmaceutical Holding Co Ltd.F Tax Payment	Chief Commercial Officer	FTax Payment	−480 sh	$90.14	−$43.3K	1,540
2020-11-25	Biohaven Pharmaceutical Holding Co Ltd.Restricted Share Unit AwardM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−1,250 sh	—	—	2,500
2020-06-10	Biohaven Pharmaceutical Holding Co Ltd.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+52K sh	$9.29	+$483K	52,770
2020-06-10	Biohaven Pharmaceutical Holding Co Ltd.S Sale	Chief Commercial Officer	SSale	−21.4K sh	$66.70	−$1.43M	31,406
2020-06-10	Biohaven Pharmaceutical Holding Co Ltd.S Sale	Chief Commercial Officer	SSale	−22.8K sh	$67.53	−$1.54M	8,568
2020-06-10	Biohaven Pharmaceutical Holding Co Ltd.S Sale	Chief Commercial Officer	SSale	−5,331 sh	$68.57	−$366K	3,237
2020-06-10	Biohaven Pharmaceutical Holding Co Ltd.S Sale	Chief Commercial Officer	SSale	−2,467 sh	$69.40	−$171K	770
2020-06-10	Biohaven Pharmaceutical Holding Co Ltd.Employee Stock Option (right to buy)M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−52K sh	—	—	37,292
2019-12-18	Biohaven Pharmaceutical Holding Co Ltd.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+1,250 sh	—	—	1,250
2019-12-18	Biohaven Pharmaceutical Holding Co Ltd.F Tax Payment	Chief Commercial Officer	FTax Payment	−480 sh	$52.13	−$25K	770
2019-12-18	Biohaven Pharmaceutical Holding Co Ltd.Restricted Share Unit AwardM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−1,250 sh	—	—	3,750
2019-11-25	Biohaven Pharmaceutical Holding Co Ltd.Employee Stock Option (Right to Buy)A Award	Chief Commercial Officer	AAward	+10K sh	—	—	10,000
2019-11-25	Biohaven Pharmaceutical Holding Co Ltd.Restricted Share Unit AwardA Award	Chief Commercial Officer	AAward	+5,000 sh	—	—	5,000
2019-03-12	Biohaven Pharmaceutical Holding Co Ltd.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+10K sh	$9.29	+$92.9K	10,000
2019-03-12	Biohaven Pharmaceutical Holding Co Ltd.S Sale	Chief Commercial Officer	SSale	−10K sh	$50.11	−$501K	0
2019-03-12	Biohaven Pharmaceutical Holding Co Ltd.Employee Stock Option (Right to Buy)M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−10K sh	—	—	78,792
2019-01-10	Biohaven Pharmaceutical Holding Co Ltd.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+10.5K sh	$9.29	+$97.5K	10,500

Recent filings

Accepted (ET)
Oct 34
Tilton John0001562180-22-006956
SEC(opens sec.gov)
Jan 74
Tilton John0001562180-22-000357
SEC(opens sec.gov)

Companies

Biohaven Pharmaceutical Holding Co Ltd.Chief Commercial Officer

Address

C/O BIOHAVEN PHARMACEUTICALS, INC. 234 CHURCH STREET

NEW HAVEN, CT, 06510